Revenue Growth Update for Q2 2024
- For April and
May 2024 , combined preliminary estimated revenue ofBiodex Medical Systems, Inc. (“Biodex”) andDaMar Plastics Manufacturing, Inc. (“DaMar”) stood at$3,970,496 with a gross margin of 36%. - As a comparison, preliminary estimated Q2 2024 revenues are projected to be 39% higher with increasing gross margins as compared to Q1 2024 revenues for Biodex and DaMar.
- In addition to intending on divesting DaMar, announced by the Company on
May 30, 2024 , in 2025, the Company plans to divest operating subsidiaries,South Dakota Partners Inc. andMio-Guard LLC , in the coming quarters to reduce debt. On a going forward basis, Evome will offer financial comparisons for its core business, Biodex, and its other remaining asset, Damar.
Details for Call-in
Dial-in number: (516) 253-3240
Access code: 918273 if prompted
Chief Executive Officer
Tel: 1 (800) 760-6826
Email: Info@Salonaglobal.com
Cautionary Statements
Neither the
Unless otherwise specified, all financial information is presented in Canadian dollars ("$", "dollars" and "C$").
There can be no assurance that any disposition (including the proposed dispositions disclosed herein) will be completed or the sale price or timing of any disposition. Completion of any transaction will be subject to, amongst other things, negotiation and execution of definitive agreements, and applicable director, shareholder and regulatory approvals.
Certain statements contained in this press release constitute "forward-looking information" within the meaning of the Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. These statements can be identified by the use of forward-looking terminology such as “expects” “believes”, “estimates”, "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", and "anticipate", and similar expressions as they relate to the Company, including: the financial results of the second quarter; and the Company successfully disposing of any subsidiaries. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions, including: the completion of normal quarter and year end accounting procedures and adjustments not resulting in any material differences; and the Company successfully identifying a buyer for a non-core business and negotiating and closing a sale. The Company cautions that the forward-looking statements contained herein are qualified by important factors that could cause actual results to differ materially from those reflected by such statements. Such factors include but are not limited to the general business and economic conditions in the regions in which the Company operates; the ability of the Company to execute on key priorities, including the successful completion of acquisitions, business retention, and strategic plans and to attract, develop and retain key executives; difficulty integrating newly acquired businesses; ongoing or new disruptions in the supply chain, the extent and scope of such supply chain disruptions, and the timing or extent of the resolution or improvement of such disruptions; the ability to implement business strategies and pursue business opportunities; disruptions in or attacks (including cyber-attacks) on the Company’s information technology, internet, network access or other voice or data communications systems or services; the evolution of various types of fraud or other criminal behavior to which the Company is exposed; the failure of third parties to comply with their obligations to the Company or its affiliates; the impact of new and changes to, or application of, current laws and regulations; granting of permits and licenses in a highly regulated business; the overall difficult litigation environment, including in
Preliminary Financial Metrics
This press release contains certain pre-released financial metrics. The financial metrics contained in this press release are preliminary and represent the most current information available to the Company's management, as financial closing procedures for the second quarter ended
![](https://ml.globenewswire.com/media/MmE4Y2Y0ZjMtZjM2ZS00MDljLTk3MTQtMWUzNmMxMmE2ZTk1LTEwOTk1NTg=/tiny/Evome-Medical-Technologies-Inc.png)
2024 GlobeNewswire, Inc., source